These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17049305)

  • 21. Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update.
    Cleland JG; Coletta AP; Cullington D; Castiello T; de Boer RA; Clark AL
    Eur J Heart Fail; 2011 Dec; 13(12):1376-80. PubMed ID: 22102626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
    Cochrane Database Syst Rev; 2004; (2):CD002901. PubMed ID: 15106182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.
    Cleland JG; Abdellah AT; Khaleva O; Coletta AP; Clark AL
    Eur J Heart Fail; 2007 Oct; 9(10):1070-3. PubMed ID: 17890152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF.
    Cleland JG; Coletta AP; Castiello T; Clark AL
    Eur J Heart Fail; 2011 Oct; 13(10):1147-51. PubMed ID: 21896537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of chronic heart failure in children.
    Ross RD
    Am J Cardiovasc Drugs; 2001; 1(1):37-44. PubMed ID: 14728050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.
    Cleland JG; Coletta AP; Abdellah AT; Nasir M; Hobson N; Freemantle N; Clark AL
    Eur J Heart Fail; 2007 Jan; 9(1):92-7. PubMed ID: 17188569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure.
    Liu LC; Dorhout B; van der Meer P; Teerlink JR; Voors AA
    Expert Opin Investig Drugs; 2016; 25(1):117-27. PubMed ID: 26587768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
    Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
    Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF.
    Thackray S; Coletta A; Jones P; Dunn A; Clark AL; Cleland JG
    Eur J Heart Fail; 2001 Aug; 3(4):491-4. PubMed ID: 11511436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.
    Cleland JG; Coletta AP; Buga L; Antony R; Pellicori P; Freemantle N; Clark AL
    Eur J Heart Fail; 2011 Apr; 13(4):460-5. PubMed ID: 21436363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.
    Cleland JG; Coletta AP; Buga L; Ahmed D; Clark AL
    Eur J Heart Fail; 2010 Jun; 12(6):623-9. PubMed ID: 20498271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current concepts in clinical therapeutics: congestive heart failure.
    Klamerus KJ
    Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
    Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
    Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
    Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
    Cleland JG; Freemantle N; Coletta AP; Clark AL
    Eur J Heart Fail; 2006 Jan; 8(1):105-10. PubMed ID: 16387630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-III.
    Cleland JG; Coletta AP; Torabi A; Ahmed D; Clark AL
    Eur J Heart Fail; 2010 Nov; 12(11):1261-4. PubMed ID: 20965880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II.
    Cleland JG; Coletta AP; Freemantle N; Clark AL
    Eur J Heart Fail; 2011 Jul; 13(7):805-8. PubMed ID: 21712293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.